ZNF322 and lung carcinoma: AKT signaling has been shown to promote ZNF322A protein stability and transcriptional activity, which in turn positively regulates transcription of alpha-adducin (ADD1) and cyclin D1 (CCND1) to promote tumorigenicity in lung cancer (19).